Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice

Cancer Letters

Volumn 126, Issue 1, 1998, Pages 49-57

  Molinolo, Alfredo ^a   Simian, Marina ^a   Vanzulli, Silvia ^a   Pazos, Patricia ^a   Lamb, Carolina ^a   Montecchia, Fernanda ^a   Lanari, Claudia ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

EGF; Mammary adenocarcinomas; Mammary glands; Medroxyprogesterone acetate; Mice; MPA; Sialoadenectomy

Indexed keywords

EPIDERMAL GROWTH FACTOR; MEDROXYPROGESTERONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST HYPERPLASIA; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HORMONAL CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; CARCINOGENS; CELL DIVISION; EPIDERMAL GROWTH FACTOR; FEMALE; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MEDROXYPROGESTERONE 17-ACETATE; MICE; MICE, INBRED BALB C; SALIVARY GLANDS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0345647110     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00527-2     Document Type: Article

References (23)

1. Lanari C., Molinolo A.A., Pasqualini C.D. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c mice. Cancer Lett. 33:1986;215-223.
2. Molinolo A.A., Lanari C., Charreau E.H., Sanjuan N., Pasqualini C.D. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. J. Natl. Cancer Inst. 79:1987;1341-1350.
3. Kordon E., Molinolo A.A., Pasqualini C.D., Dran G., Lanari C. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between hormone dependence and morphology. Breast Cancer Res. Treat. 28:1993;29-39.
4. Kordon E., Guerra F., Molinolo A.A., Elizalde P., Charreau E.H., Pasqualini C.D., Montecchia F., Lanari C. Effect of sialoadenectomy on medroxyprogesterone acetate (MPA)-induced mammary carcinogenesis in BALB/c mice. Int. J. Cancer. 59:1994;196-203.
5. Pazos P., Lanari C., Meiss R., Charreau E.H., Pasqualini C.D. Mammary carcinogenesis induced by N-methyl-N-nitrosourea and medroxyprogesterone acetate in BALB/c mice. Breast Cancer Res. Treat. 20:1992;133-138.
6. Dran G., Luthy I., Molinolo A., Charreau E.H., Montecchia M.F., Pasqualini C.D., Lanari C. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma. Breast Cancer Res. Treat. 35:1995;173-186.
7. Bullock L.P., Barthe T.H., Mawzowicz I., North A., Bardin C.W. The effect of progestin on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and anti-androgenic actions. Endocrinology. 97:1975;189-195.
8. Snedeker S.M., Brown C.F., Di Augustine R.P. Expression and functional properties of transforming growth factor α and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc. Natl. Acad. Sci. USA. 88:1991;276-280.
9. Coleman S., Silberstein G.B., Daniel C.W. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev. Biol. 127:1988;304-315.
10. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J. Biol. Chem. 237:1962;1555-1562.
11. Kurachi H., Okamoto S., Oka T. Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis. Proc. Natl. Acad. Sci. USA. 82:1985;5940-5943.
12. Derynck R. Transforming factor alpha. Cell. 54:1988;593-595.
13. 131I] human EGF and kidney histochemistry. Clin. Exp. Pharmacol. Physiol. 19:1992;667-673.
14. I. Russo, M. Tewari, J. Russo, Morphology and development of the mammary gland, in: T.C. Jones, U. Mohr, R.D. Hunt (Eds.), Integument and Mammary Glands of Laboratory Animals, Springer-Verlag, Berlin, 1989, pp. 233-252.
15. Levi-Montalcini R., Angeletti P.U. Nerve growth factor. Physiol. Rev. 48:1968;534-569.
16. Maruyama S., Hosoi K., Ueha T., Tajima M., Sato S., Gresik E. Effects of female hormones and 3,5,3′-triiodothyronine or dexamethasone on induction of epidermal growth factor and proteinases F, D, A and P in the submandibular glands of hypophysectomized male mice. Endocrinology. 133:1993;1051-1060.
17. Vonderhhar B.K. Local effects of EGF, alpha TGF, and EGF like growth factors on lobuloalveolar developmental of the mouse mammary gland in vivo. J. Cell Physiol. 132:1987;581-584.
18. Stoscheck C.M., King L. Role of epidermal growth factor in carcinogenesis. Cancer Res. 46:1986;1030-1037.
19. E.H. Charreau, P. Elizalde, F. Guerra, C. Lanari, E. Kordon, C.D. Pasqualini, Growth factors in murine mammary adenocarcinomas induced by progestins, in: J. Li, S. Nandi (Eds.), Hormonal Carcinogenesis, Springer-Verlag, New York, 1991, pp. 138-144.
20. Klijn J.G.M., Berns P.M.J.J., Schmitz P.I.M., Foekens J.A. The clinical significance of epidermal growth factor (EGF-R) in human breast cancer: a review. Endocr. Rev. 13:1992;3-17.
21. Imagawa W., Tomooka Y., Hamamoto S., Nandi S. Stimulation of mammary epithelial cell growth in vitro: interaction of epidermal growth factor and mammogenic hormones. Endocrinology. 116:1985;1514-1524.
22. Kienhuis C.B., Sluyser M., de Goeij C.C., Koenders P.G., Benraad T.J. Epidermal growth factor receptor levels increase but epidermal growth factor levels decrease in mouse mammary tumors during progression from hormone dependence to hormone independence. Breast Cancer Res. Treat. 26:1993;289-295.
23. Bunone G., Briand P.A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:1996;2174-2183.